- Joined
- Apr 7, 2008
- Messages
- 178
- Reaction score
- 0
There are 2 groups of lysosomal storage diseases. In Group I, there are 2 diseases, Smith syndrome and Jones syndrome, each of which is lacking a different lysosomal hydrolase, resulting in accumulation of a glycosaminoglycan within lysosomes. There is an isolated cells from patients with Smith syndrome and patients with Jones syndrome. When cells from the 2 syndromes are fused, glycosaminoglycans are now degraded properly.
In addition, surprisingly, when the medium (supernatant = solution outside of the cells) from a culture of Smith cells (donor) is added to a culture of Jones cells (recipient), the Jones defect is corrected (Jones glycosaminoglycan is now degraded).
-----Questions that I have
I don't understand how cellular fusion (in the first part) corrects the defects in the Smith and Jones cells?
What is the corrective factor (and how does it work) in the medium/supernatant? And how does the corrective factor from the Smith cells get into the Jones cell to correct the defect?
In addition, surprisingly, when the medium (supernatant = solution outside of the cells) from a culture of Smith cells (donor) is added to a culture of Jones cells (recipient), the Jones defect is corrected (Jones glycosaminoglycan is now degraded).
-----Questions that I have
I don't understand how cellular fusion (in the first part) corrects the defects in the Smith and Jones cells?
What is the corrective factor (and how does it work) in the medium/supernatant? And how does the corrective factor from the Smith cells get into the Jones cell to correct the defect?